Zeitschrift für Gastroenterologie, Table of Contents Z Gastroenterol 2001; 39(1): 43-45DOI: 10.1055/s-2001-10698 Leitlinien der DGVS© Karl Demeter Verlag im Georg Thieme Verlag Stuttgart · New YorkChronisch-aktiver VerlaufJ. Schölmerich Regensburg Recommend Article Abstract Buy Article Full Text References Literatur 1 Rosenberg J L, Wall A J, Levin B. et al . A controlled trial of azathioprine in the management of chronic ulcerative colitis. Gastroenterology. 1975; 69 96-99 (I b) 2 Kirk A P, Lennard-Jones J E. Controlled trial of azathioprine in chronic ulcerative colitis. BMJ (Clin. Res. Ed). 1982; 284 1291-1292 (I b) 3 Hawthorne A B, Logan R F, Hawkey C J. et al . Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ. 1992; 305 20-22 (I b) 4 Jewell D P, Truelove S C. Azathioprine in ulcerative colitis: Final report on controlled therapeutic trial. BMJ. 1974; 4 627-630 (I b) 5 Schölmerich J. Indikation für eine immunsuppressive Therapie bei chronisch-entzündlichen Darmerkrankungen. Internist. 1997; 38 582-589 (IV) 6 Schölmerich J. Immunosuppressive treatment for refractory ulcerative colitis - where do we stand and where are we going?. Eur J Gastroenterol Hepatol. 1997; 9 842-849 (IV) 7 Pemberton J H, Kella K A, Beart R W. et al . Ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg. 1987; 206 504-513 (III) 8 Griffin M G, Miner P B. Refractory distal colitis - explanations and options. Aliment Pharmacol Ther. 1996; 10 39-48 (IV) 9 Adler D J, Korelitz B I. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. Am J Gastroenterol. 1990; 85 717-722 (III) 10 George J, Present D H, Pou R. et al . 6-Mercaptopurine for the treatment of ulcerative colitis. Am J Gastroenterol. 1996; 91 1711-1714 (III) 11 Schölmerich J. Which immunosuppressors do you use to treat Crohn’s disease and ulcerative colitis? In which order of priority and how worried are you about toxicity?. Inflamm Bowel Dis. 1998; 4 248-252 (IV) 12 Kjeldsen J. Treatment of ulcerative colitis with high doses of oral prednisolone. The rate of remission, the need for surgery, and the effect of prolonging the treatment. Scand J Gastroenterol. 1993; 28 821-826 (III) 13 Oren R, Arber N, Odes S. et al . Methotrexate in chronic active ulcerative colitis: A double-blind, randomized, Israeli multicenter trial. Gastroenterol. 1996; 110 1416-1421 (I b) 14 Turunen U M, Färkkilä M A, Hakala K. et al . Long-term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-blind, placebo-controlled study. Gastroenterology. 1998; 115 1072-1078 (I b) 15 Sandborn W J, Tremaine W J, Schroeder K W. et al . A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. Gastroenterology. 1994; 106 1429-1435 (I b) 16 Present D H, Meltzer S J, Krumholz M P. et al . 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity. Ann Intern Med. 1989; 111 641-649 (III) 17 Bouhnik Y, Lémann M, Mary J Y. et al . Long-term follow-up of patients with Crohn’s disease treated with azathioprine or 6-mercaptopurine. Lancet. 1996; 347 215-219 (III) 18 Kader H A, Mascarenhas M R, Piccoli D A. et al . Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. J Pediatr Gastroenterol Nutr. 1999; 28 54-58 (III) 19 Alstead E M, Ritchie J K, Lennard-Jones J E. et al . Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology. 1990; 99 443-446 (III) 20 Kozarek R A, Patterson D J, Gelfand M D. et al . Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 1989; 110 353-356 (II b) 21 Kozarek R A. Methotrexate and ulcerative colitis: Wrong drug? Wrong dose? Or wrong disease?. Gastroenterology. 1996; 110 1652-1656 (IV) 22 Fellermann K, Ludwig D, Stahl M. et al . Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by Tacrolimus (FK506). Am J Gastroenterol. 1998; 93 1860-1866 (II b) 23 Gaffney P R, Doyle C T, Gaffney A. et al . Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol. 1995; 90 220-223 (II b) 24 Sümer N, Palabiyikoglu M. Induction of remission by interferon-α in patients with chronic active ulcerative colitis. Eur J Gastroenterol Hepatol. 1995; 7 597-602 (II b) 25 Actis G C, Aimo G, Priolo G. et al . Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: An open-label retrospective trial. Inflamm Bowel Dis. 1998; 4 276-279 (III) 26 Evans R C, Clarke L, Heath P. et al . Treatment of ulcerative colitis with an engineered human anti-TNF alpha antibody CDP571. Aliment Pharmacol Ther. 1997; 11 1031-1035 (II b)
